Analyses the coding sequence of the CEBPA gene for clinically relevant mutations associated with acute myeloid leukaemia.
Used in people with suspected or confirmed acute myeloid leukaemia to support disease classification and prognostic assessment. It is not a general inherited-cancer screening test.